Chemoinformaics analysis of 8-METHYL-3,4-DIHYDRO-1H-PYRANO[3,4-C]PYRIDIN-1-OL
| Molecular Weight | 165.192 | nRot | 0 |
| Heavy Atom Molecular Weight | 154.104 | nRig | 11 |
| Exact Molecular Weight | 165.079 | nRing | 2 |
| Solubility: LogS | -0.513 | nHRing | 2 |
| Solubility: LogP | 0.367 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 25.0687 |
| nHD | 1 | BPOL | 13.9113 |
| QED | 0.622 |
| Synth | 3.441 |
| Natural Product Likeliness | 1.219 |
| NR-PPAR-gamma | 0.27 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.015 |
| HIA | 0.006 |
| CACO-2 | -4.314 |
| MDCK | 0.0000208 |
| BBB | 0.493 |
| PPB | 0.27367 |
| VDSS | 2.926 |
| FU | 0.708542 |
| CYP1A2-inh | 0.062 |
| CYP1A2-sub | 0.658 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.887 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.432 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.709 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.441 |
| CL | 2.435 |
| T12 | 0.738 |
| hERG | 0.021 |
| Ames | 0.3 |
| ROA | 0.084 |
| SkinSen | 0.415 |
| Carcinogencity | 0.414 |
| EI | 0.921 |
| Respiratory | 0.381 |
| NR-Aromatase | 0.682 |
| Antiviral | No |
| Prediction | 0.870845 |